This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Exosomes Europe
5-6 June 2024
DoubleTree Tower of London

Dr Dave Mentlak
Senior Scientist at Mesenbio


As a Senior Scientist at Mesenbio, Dave is at the forefront of developing MEV-N01, an innovative regenerative therapy for arthritic diseases. With over eight years bridging the gap between academic research and industry application, Dave has a track record of enhancing therapeutic antibody production in Chinese Hamster Ovary (CHO) cells, working in tandem with entities like Fujifilm Diosynth Biotechnologies and the University of York. His experience encompasses critical aspects of biologics production, such as cell growth, yield and product quality improvement. At Mesenbio, Dave utilises his extensive background in cell biology and bioprocessing knowledge to propel the development of therapeutic EVs, contributing to the company’s cutting-edge solutions in regenerative medicine

Agenda Sessions

  • Finding the Right MSC for EV Therapeutics

  • Talk Title TBC

  • Chair’s Welcome Remarks